Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Published:2020-01 Issue:1 Volume:75 Page:84-104
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Levey Andrew S.,Gansevoort Ron T.,Coresh Josef,Inker Lesley A.,Heerspink Hiddo L.,Grams Morgan E.,Greene Tom,Tighiouart Hocine,Matsushita Kunihiro,Ballew Shoshana H.,Sang Yingying,Vonesh Edward,Ying Jian,Manley Tom,de Zeeuw Dick,Eckardt Kai-Uwe,Levin Adeera,Perkovic Vlado,Zhang Luxia,Willis Kerry

Funder

Alexion

Astellas

AstraZeneca

Bayer

Boehringer-Ingelheim

Gilead

Ironwood

Kyowa Hakko Kirin

Merck

Novartis

Novo-Nordisk

National Institutes of Health

Siemens

NIH

NKF

Tufts Medical Center

Abbvie

Boehringer Ingelheim

Merck (all

GSK

Novo Nordisk

Ipsen

Sanofi-Genzyme

Publisher

Elsevier BV

Subject

Nephrology

Reference49 articles.

1. Action plan for optimizing the design of clinical trials in chronic kidney disease;Perkovic;Kidney Int Suppl,2017

2. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference;Baigent;Kidney Int,2017

3. The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov;Inrig;Am J Kidney Dis,2014

4. Trial quality in nephrology: how are we measuring up?;Palmer;Am J Kidney Dis,2011

5. Assessing the validity of surrogate outcomes for ESRD: a meta-analysis;Jun;J Am Soc Nephrol,2015

Cited by 350 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of major candidate protein biomarkers and long-term diabetic kidney disease progression among Asians with young-onset type 2 diabetes mellitus;Diabetes Research and Clinical Practice;2024-10

2. Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure?;Journal of the American College of Cardiology;2024-09

3. Prevalence and Risk Factors of Chronic Kidney Disease in Patients With Type 2 Diabetes in China: Cross-Sectional Study;JMIR Public Health and Surveillance;2024-08-30

4. Association between Systemic Immune-inflammation Index and Decreased Kidney Function in Patients with Early Chronic Kidney Disease: A Retrospective Study;2024-08-28

5. Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care;Diabetologia;2024-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3